SlideShare a Scribd company logo
1 of 30
National Guidelines Dr Pradeep Haldar Assistant Commissioner GoI
Why monitor AEFI? ,[object Object],[object Object],[object Object],[object Object]
What to Report ,[object Object],[object Object],[object Object],[object Object],[object Object]
HOW , WHOM & WHEN TO REPORT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
HOW , WHOM & WHEN TO REPORT ,[object Object],[object Object],[object Object],[object Object],[object Object]
HOW , WHOM & WHEN TO REPORT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
HOW , WHOM & WHEN TO REPORT ,[object Object],[object Object],[object Object],[object Object]
 
Role & Responsibilities of key players……1(ANM)  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Role & Responsibilities of key players……2 (ANM) ,[object Object],[object Object],[object Object],[object Object],[object Object]
Role & Responsibilities of key players……3 (HS) ,[object Object],[object Object],[object Object],[object Object],[object Object]
Role & Responsibilities of key players……4 (MO) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Role & Responsibilities of key players……5 (MO) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Role & Responsibilities of key players……6 (District level staff) ,[object Object],[object Object],[object Object],[object Object]
Role & Responsibilities of key players……7 (District level staff) ,[object Object],[object Object],[object Object],[object Object]
Role & Responsibilities of key players……8 (District level staff) ,[object Object],[object Object],[object Object]
Role & Responsibilities of key players……9 (District level staff) ,[object Object],[object Object],[object Object],[object Object]
Role & Responsibilities of key players……10 (State level staff) ,[object Object],[object Object],[object Object],[object Object],[object Object]
Role & Responsibilities of key players……11 (State level staff) ,[object Object],[object Object],[object Object],[object Object],[object Object]
Role & Responsibilities of key players……12 (State level staff) ,[object Object],[object Object],[object Object]
Role & Responsibilities of key players……13 (State level staff) ,[object Object],[object Object],[object Object]
Role of State Regulatory Authority (SRA), NRA and NCL ,[object Object],[object Object],[object Object],[object Object]
Regional Investigation Teams ,[object Object],[object Object]
State Expert Committee on AEFI ,[object Object],[object Object],[object Object],[object Object]
State Expert Committee on AEFI ,[object Object],[object Object],[object Object],[object Object]
State Expert Committee on AEFI ,[object Object],[object Object],[object Object]
National Expert committee on AEFI ,[object Object],[object Object],[object Object],[object Object]
National Expert committee on AEFI ,[object Object],[object Object],[object Object],[object Object],[object Object]
National Expert committee on AEFI ,[object Object],[object Object]
Thank You

More Related Content

What's hot

Management information system (MIS)
Management information system (MIS)Management information system (MIS)
Management information system (MIS)BPKIHS
 
Health Management Information System in Ethiopia
Health Management Information System in EthiopiaHealth Management Information System in Ethiopia
Health Management Information System in EthiopiaMEASURE Evaluation
 
Mis in hospitals
Mis in hospitalsMis in hospitals
Mis in hospitalsathul cs
 
HEALTH MANAGEMENT INFORMATION SYSTEM - TAMILNADU HEALTH SYSTEM PROJECT
HEALTH MANAGEMENT INFORMATION SYSTEM - TAMILNADU HEALTH SYSTEM PROJECTHEALTH MANAGEMENT INFORMATION SYSTEM - TAMILNADU HEALTH SYSTEM PROJECT
HEALTH MANAGEMENT INFORMATION SYSTEM - TAMILNADU HEALTH SYSTEM PROJECTRamamanohari Seetharaman
 

What's hot (8)

Sentinel Events & OVR (lecture)
Sentinel Events & OVR (lecture)Sentinel Events & OVR (lecture)
Sentinel Events & OVR (lecture)
 
How to report an SAE
How to report an SAEHow to report an SAE
How to report an SAE
 
Hmis
HmisHmis
Hmis
 
Management information system (MIS)
Management information system (MIS)Management information system (MIS)
Management information system (MIS)
 
Health Management Information System in Ethiopia
Health Management Information System in EthiopiaHealth Management Information System in Ethiopia
Health Management Information System in Ethiopia
 
KENNIA M (1)
KENNIA M (1)KENNIA M (1)
KENNIA M (1)
 
Mis in hospitals
Mis in hospitalsMis in hospitals
Mis in hospitals
 
HEALTH MANAGEMENT INFORMATION SYSTEM - TAMILNADU HEALTH SYSTEM PROJECT
HEALTH MANAGEMENT INFORMATION SYSTEM - TAMILNADU HEALTH SYSTEM PROJECTHEALTH MANAGEMENT INFORMATION SYSTEM - TAMILNADU HEALTH SYSTEM PROJECT
HEALTH MANAGEMENT INFORMATION SYSTEM - TAMILNADU HEALTH SYSTEM PROJECT
 

Similar to 06 introduction to guidelines

AEFI p haldar presentation for sepio meet
AEFI    p haldar presentation for sepio meetAEFI    p haldar presentation for sepio meet
AEFI p haldar presentation for sepio meetPrabir Chatterjee
 
Materiovigilance and AEFI ppt
Materiovigilance and AEFI pptMateriovigilance and AEFI ppt
Materiovigilance and AEFI pptJuliaWilson68
 
Ipc aefi surveillance_program_in_india
Ipc aefi surveillance_program_in_indiaIpc aefi surveillance_program_in_india
Ipc aefi surveillance_program_in_indiank999999
 
Critical review of idsp
Critical review of idspCritical review of idsp
Critical review of idspAbhi Manu
 
Current Pharmacovigilance Practice And Improving Methods
Current Pharmacovigilance Practice And Improving MethodsCurrent Pharmacovigilance Practice And Improving Methods
Current Pharmacovigilance Practice And Improving Methodsavinashkhairnar
 
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCE
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCEAN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCE
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCERamakrishna K
 
Child death review guidelines
Child death review guidelinesChild death review guidelines
Child death review guidelinesdpmo123
 
Drug Safety Regulations In The Us And Eu
Drug Safety Regulations In The Us And EuDrug Safety Regulations In The Us And Eu
Drug Safety Regulations In The Us And EuAngelinabarfield
 
08 ap model- aefi - 08-11-05 - chandigarh
08 ap model- aefi - 08-11-05 - chandigarh08 ap model- aefi - 08-11-05 - chandigarh
08 ap model- aefi - 08-11-05 - chandigarhPrabir Chatterjee
 
Presentation 4 mdr -goi-guidelines wb-2011
Presentation 4  mdr -goi-guidelines wb-2011Presentation 4  mdr -goi-guidelines wb-2011
Presentation 4 mdr -goi-guidelines wb-2011Prabir Chatterjee
 
UP status Child Death Review.ppt
UP status Child Death Review.pptUP status Child Death Review.ppt
UP status Child Death Review.pptSanjeevDavey1
 
International Patient Safety Goals
International Patient Safety GoalsInternational Patient Safety Goals
International Patient Safety GoalsLallu Joseph
 
Introduction to the Progressive Control Pathway
Introduction to the Progressive Control PathwayIntroduction to the Progressive Control Pathway
Introduction to the Progressive Control PathwayFAO
 
Advances in animal health management system & use of epidemiological tools
Advances in animal health management system & use of epidemiological toolsAdvances in animal health management system & use of epidemiological tools
Advances in animal health management system & use of epidemiological toolsSharadindu Shil
 
4.3 Case Investigation SoP Part 3_edited_version_Jan_2023.pptx.pptx
4.3 Case Investigation SoP Part 3_edited_version_Jan_2023.pptx.pptx4.3 Case Investigation SoP Part 3_edited_version_Jan_2023.pptx.pptx
4.3 Case Investigation SoP Part 3_edited_version_Jan_2023.pptx.pptxEtalemBurako
 
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Act
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics ActPharmacovigilance and Materiovigilance, Drugs and Cosmetics Act
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Actshashi sinha
 
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Act 1940
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Act 1940Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Act 1940
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Act 1940shashi sinha
 

Similar to 06 introduction to guidelines (20)

AEFI guidelines
AEFI guidelinesAEFI guidelines
AEFI guidelines
 
AEFI p haldar presentation for sepio meet
AEFI    p haldar presentation for sepio meetAEFI    p haldar presentation for sepio meet
AEFI p haldar presentation for sepio meet
 
Materiovigilance and AEFI ppt
Materiovigilance and AEFI pptMateriovigilance and AEFI ppt
Materiovigilance and AEFI ppt
 
AFP Surveillance (For Undergraduates)
AFP Surveillance (For Undergraduates)AFP Surveillance (For Undergraduates)
AFP Surveillance (For Undergraduates)
 
Ipc aefi surveillance_program_in_india
Ipc aefi surveillance_program_in_indiaIpc aefi surveillance_program_in_india
Ipc aefi surveillance_program_in_india
 
Critical review of idsp
Critical review of idspCritical review of idsp
Critical review of idsp
 
Current Pharmacovigilance Practice And Improving Methods
Current Pharmacovigilance Practice And Improving MethodsCurrent Pharmacovigilance Practice And Improving Methods
Current Pharmacovigilance Practice And Improving Methods
 
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCE
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCEAN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCE
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCE
 
Child death review guidelines
Child death review guidelinesChild death review guidelines
Child death review guidelines
 
Drug Safety Regulations In The Us And Eu
Drug Safety Regulations In The Us And EuDrug Safety Regulations In The Us And Eu
Drug Safety Regulations In The Us And Eu
 
08 ap model- aefi - 08-11-05 - chandigarh
08 ap model- aefi - 08-11-05 - chandigarh08 ap model- aefi - 08-11-05 - chandigarh
08 ap model- aefi - 08-11-05 - chandigarh
 
Presentation 4 mdr -goi-guidelines wb-2011
Presentation 4  mdr -goi-guidelines wb-2011Presentation 4  mdr -goi-guidelines wb-2011
Presentation 4 mdr -goi-guidelines wb-2011
 
Mdsr ppt
Mdsr pptMdsr ppt
Mdsr ppt
 
UP status Child Death Review.ppt
UP status Child Death Review.pptUP status Child Death Review.ppt
UP status Child Death Review.ppt
 
International Patient Safety Goals
International Patient Safety GoalsInternational Patient Safety Goals
International Patient Safety Goals
 
Introduction to the Progressive Control Pathway
Introduction to the Progressive Control PathwayIntroduction to the Progressive Control Pathway
Introduction to the Progressive Control Pathway
 
Advances in animal health management system & use of epidemiological tools
Advances in animal health management system & use of epidemiological toolsAdvances in animal health management system & use of epidemiological tools
Advances in animal health management system & use of epidemiological tools
 
4.3 Case Investigation SoP Part 3_edited_version_Jan_2023.pptx.pptx
4.3 Case Investigation SoP Part 3_edited_version_Jan_2023.pptx.pptx4.3 Case Investigation SoP Part 3_edited_version_Jan_2023.pptx.pptx
4.3 Case Investigation SoP Part 3_edited_version_Jan_2023.pptx.pptx
 
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Act
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics ActPharmacovigilance and Materiovigilance, Drugs and Cosmetics Act
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Act
 
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Act 1940
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Act 1940Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Act 1940
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Act 1940
 

More from Prabir Chatterjee (20)

Health System
Health SystemHealth System
Health System
 
Safe water modified
Safe water  modifiedSafe water  modified
Safe water modified
 
Cycles in community health
Cycles in community healthCycles in community health
Cycles in community health
 
Medical Ethics Vivekananda Arogya Ddham
Medical Ethics Vivekananda Arogya DdhamMedical Ethics Vivekananda Arogya Ddham
Medical Ethics Vivekananda Arogya Ddham
 
Acute chest syndrome (sickle cell)
Acute chest syndrome (sickle cell)Acute chest syndrome (sickle cell)
Acute chest syndrome (sickle cell)
 
Comprehensive Primary Health Care
Comprehensive Primary Health CareComprehensive Primary Health Care
Comprehensive Primary Health Care
 
Abhiskaar
AbhiskaarAbhiskaar
Abhiskaar
 
Cup that runneth over
Cup that runneth overCup that runneth over
Cup that runneth over
 
Janani suraksha ii jcm
Janani suraksha ii jcmJanani suraksha ii jcm
Janani suraksha ii jcm
 
Maa ki suraksha jcm
Maa ki suraksha jcmMaa ki suraksha jcm
Maa ki suraksha jcm
 
Diabetic diet cmc
Diabetic diet cmcDiabetic diet cmc
Diabetic diet cmc
 
Ntui 18 12-2012
Ntui 18 12-2012Ntui 18 12-2012
Ntui 18 12-2012
 
Doctor and family!
Doctor and family!Doctor and family!
Doctor and family!
 
Nssk adibasi udj jetha murmu
Nssk adibasi udj jetha murmuNssk adibasi udj jetha murmu
Nssk adibasi udj jetha murmu
 
29 th mela pratapur googowak' lagre enec competition
29 th mela pratapur   googowak' lagre enec competition29 th mela pratapur   googowak' lagre enec competition
29 th mela pratapur googowak' lagre enec competition
 
Nonadanga slum
Nonadanga slumNonadanga slum
Nonadanga slum
 
Telephone 5 months dead
Telephone 5 months deadTelephone 5 months dead
Telephone 5 months dead
 
Malaria and kala azar ranchi 2012
Malaria and kala azar ranchi 2012Malaria and kala azar ranchi 2012
Malaria and kala azar ranchi 2012
 
Nest of corruption
Nest of corruptionNest of corruption
Nest of corruption
 
Hleg bengali
Hleg bengaliHleg bengali
Hleg bengali
 

06 introduction to guidelines

  • 1. National Guidelines Dr Pradeep Haldar Assistant Commissioner GoI
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.  
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.

Editor's Notes

  1. Minor AEFI are to be reported by the ANM to the MO PHC in the monthly reports who will include the report from all ANM in the monthly report to the District. The DIO reports this in the monthly report to the state and the state to the GoI as per the timeline for monthly report.
  2. The serious events are to be reported by the ANM to the MO (PHC) immediately by telephone or any other fastest means of communication. The MO (PHC) will fill the First Information Report (FIR) and forward a copy to the DIO immediately (maximum within 24 hrs). The DIO will forward the copy of the AC (UIP), GoI and to the SEPIO within next 24 hrs. The DIO will then conduct the preliminary investigation and forward a PIR to be the AC (UIP) and the SEPIO within 7 days of the AE. This report will include the probable cause of death and also mention the further investigation planned for the case.
  3. The DIO along with the Regional investigation team or the state investigation team will conduct the detailed investigation. This team will forward the report (DIR) along with all relevant documents like Post mortem report, vaccine test report, any other medical documents of the case to the AC (UIP) within 90 days of the AE. Field workers are encouraged to report AEFIs even if there is uncertainty about whether the event was caused by the vaccine and even if there is a delay in the submission of the report.
  4. Detection of AEFIs Treatment of mild symptoms like fever Reporting of serious events immediately to the MO (PHC) Reporting of minor events (e.g. local abscesses at the site of DPT immunization; occurrence of draining lymphadenitis of the BCG vaccinated limb etc) in the regular monthly reporting system.
  5. Help the MO (PHC) in preliminary investigation of AEFI. Communication with parents and other members of the community, specially rumors or public enquiries. Corrective action: They may initiate action themselves if it is clear what to do (e.g. improve injection practices in case of an abscess). Corrective action in response to the guidance from the MO (PHC)
  6. Health Supervisors He/ She should monitor the community for adverse events during their supervisory visits to immunization sites/ SC. Provide on job training to the field staff on the safe injection practices. Assist the MO in collecting and compiling report from the ANM Assist the MO in conducting the investigation
  7. MO PHC responsibilities include: Management of AEFIs and referral to next higher level if required. Initiating investigation when required Completing case report forms- FIR, PIR and DIR if required. Inform DIO immediately of serious cases and deaths Reports all DPT site abscesses that occur within 2 weeks of immunization and draining lymphadenitis at any time after immunization in the monthly report form to DIO. The MO must mention in the report non-occurrence of these events in the PHC (A NIL REPORT IS ALSO AS IMPORTANT)
  8. Training: Staff to be trained in diagnosing, treating and reporting of AEFIs and differentiating between minor, non significant reactions and more serious events. Solving operational problems through training in order to improve the skills & knowledge of the workers. Communication with the health workers and the community. The public should be informed about what is being done in the investigation and when over the conclusions and results should be shared with the workers and the community. Correction of the problem: Logistics: Improving/arranging logistics in case programme errors are due to lack of appropriate supplies or equipment, or failure in the cold chain Supervision: Non serious events reported should be supervised by site visits and immediate feedback should be given to the health worker on their AEFI activities. Regular supervisory visits for monitoring the routine immunization program should be utilized to detect problems in reporting or identifying the programme errors. Intensified supervision in cases of serious/ cluster of AEFIs to correct the programme errors.
  9. DIO to monitor that the Sentinel surveillance is carried out for all AEFI using existing sentinel sites for vaccine-preventable diseases. It is carried out through those hospitals having large paediatric outpatient & inpatient departments and MCH clinics where children with adverse events are more likely to report. Appropriate record maintenance and reporting of non-occurrence of such cases is an integral part of the sentinel surveillance. Sentinel surveillance will attempt to highlight whether the AEFI is due to vaccine or programmatic errors or coincidental
  10. DIO will compile these data centrally for each diagnostic type of AEFI and disseminate this information to field personnel, state government. DIO must mention in the report non-occurrence of these events in the district (A NIL REPORT IS ALSO AS IMPORTANT) Training of MO PHC in diagnosing, treating and reporting of AEFI and differentiating between mild, non significant reactions and more serious events.
  11. Communication with the health workers and the community and the media if required. They should be informed about what is being done in the investigation and the conclusions and results should be shared with them at the end of the investigation. Correction of the problem: By arranging logistics in case of lack of supplies; Training; Supervision as detailed above.
  12. State Level (Players: Dept of FW, SEPIO, and State level Investigation Teams) Training: They will train the district level staff in diagnosis, treatment and reporting AEFIs and differentiating between minor, non significant reactions and more serious ones. Ensuring investigation of clusters, serious events, unusual events: following a report of serious AEFI, the manager will investigate, collect & report data. This may be under supervision of national team, if required Inform AC (UIP) immediately of serious cases and deaths (SEPIO) Regulatory action, if required
  13. Corrective (programmatic) action as detailed above Point of contact for state AEFI surveillance (SEPIO). Receive, analyze and report on AEFI case reports (SEPIO) SEPIO will compile these data at state level for the districts for each diagnostic type of AEFI and disseminate this information to Government of India. SEPIO must mention in the report non-occurrence of these events in the state (A NIL REPORT IS ALSO AS IMPORTANT) Produces a regular line listing of the reports received, and the conclusion of the investigation and send these reports to the AC (UIP) on regular and timely basis
  14. Communication with the health workers and the community and the media if required. They should be informed about what is being done in the investigation and the conclusions and results should be shared with them when the investigation is over.
  15. Regional Investigation Teams if required and established (based on large geographical area or population and the expertise available) is composed of a pediatrician, an epidemiologist and a microbiologist. The teams will function primarily to investigate serious AEFIs and deaths (investigation will be initiated within 24 hours of being reported to the team).
  16. Composed of NRA representative, AC (UIP), Senior Paediatrician, infectious disease physician, neurologist, Immunologist, Epidemiologist, and possibly a pharmacologist/toxicologist,- The committee will meet at least twice a year Provides the causality assessment on investigations which have not reached conclusions; provides quality control on system Help in investigating AE when requested by the state.